日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma

STELLAR:一项III期、随机、开放标签研究,比较依氟鸟氨酸联合洛莫司汀与单用洛莫司汀治疗复发性3级星形细胞瘤患者的疗效

Colman, Howard; Lombardi, Giuseppe; Wong, Eric T; Walbert, Tobias; Eoli, Marica; Lassman, Andrew B; Peereboom, David M; Kizilbash, Sani H; Kamiya-Matsuoka, Carlos; Pitz, Marshall W; Strowd, Roy E; Desjardins, Annick; Kumthekar, Priya; Mason, Warren; Pellerino, Alessia; Soffietti, Riccardo; Butowski, Nicholas; Forsyth, Peter A; Hamza, Mohamed A; Hau, Peter; Lallana, Enrico; Nabors, Burt; Piccioni, David; Uhlmann, Erik J; Welsh, Liam C; Wen, Patrick Y; Dietrich, Jorg; Wang, Chao; Levin, Victor A

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial

Olutasidenib治疗复发/再发性局部晚期或转移性IDH1突变软骨肉瘤:1b/2期试验

Jones, Robin L; Groisberg, Roman; Blay, Jean-Yves; Colman, Howard; De La Fuente, Macarena; Roxburgh, Patricia; Chao, Mwe Mwe; Tian, Hua; Duffaud, Florence; Bahleda, Rastislav; Van Tine, Brian A

New-onset prediabetes/diabetes worsens overall survival in patients with cancer: A real-world retrospective cohort study

新发糖尿病前期/糖尿病会降低癌症患者的总体生存率:一项真实世界回顾性队列研究

Winn, Maci; Pauleck, Svenja; Richardson, Stephanie; Viskochil, Richard; Karra, Prasoona; Colman, Howard; Doherty, Jennifer A; Xu, Yizhe; Hu-Lieskovan, Siwen; Litchman, Michelle; Playdon, Mary C; Hardikar, Sheetal

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial

节拍式口服帕唑帕尼联合拓扑替康治疗复发性胶质母细胞瘤(伴或不伴贝伐单抗治疗):一项 II 期临床试验的结果

Ozer, Byram H; Cohen, Adam L; Colman, Howard; Penas-Prado, Marta; de Groot, John; Loghin, Monica E; Pan, Edward; Raizer, Jeffrey J; Kumthekar, Priya; Fink, Karen L; Walbert, Tobias; Merrell, Ryan T; Groves, Morris D; Ahluwalia, Manmeet S; Wu, Jing; Burton, Eric C; Vera, Elizabeth; Mendoza, Tito; Grajkowska, Ewa; Wall, Kathleen; Reyes, Jennifer; Yuan, Ying; Armstrong, Terri S; Gilbert, Mark R

NG2-targeting macrophages inhibit 3D invasion of patient-derived glioblastoma spheroids

靶向NG2的巨噬细胞抑制患者来源的胶质母细胞瘤球体的三维侵袭

Kurudza, Elena; Varady, Sophia R S; Greiner, Daniel; Marvin, James E; Ptacek, Alyse; Rodriguez, Melanie; Mishra, Abhinava K; He, Gongping; Dotti, Gianpietro; Colman, Howard; Reeves, Melissa Q; Montell, Denise J; Cheshier, Samuel H; Roh-Johnson, Minna

Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysis

在“癌症综合治疗(TCC)研究”中,对肿瘤患者营养不良风险的循环脂质组学生物标志物进行鉴定:一项横断面分析

Hoobler, Rachel; Maschek, J Alan; Luo, Bai; Murphy, E Angela; Kubinak, Jason L; Stewart, Paul A; Cox, James E; Chaix, Amandine; Woodruff, Kary; Sanchez, Alejandro; Coletta, Adriana M; Tabung, Fred K; Gupta, Sumati; Hardikar, Sheetal; Colman, Howard; Playdon, Mary C

Comprehensive analysis of TEAD inhibition in meningioma identifies MEK and mTOR inhibition as effective combination therapies against resistant lines.

对脑膜瘤中 TEAD 抑制的综合分析表明,MEK 和 mTOR 抑制是对抗耐药细胞系的有效联合疗法。

Keiser Dylan J, Buddy Meghan S, Mojarad-Jabali Solmaz, Li Qing, Kohler-Skinner Missia, Parrish Abigail G, Gillespie David, Nix David, Holmen Sheri, Colman Howard, Couldwell William, Jensen Randy, Szulzewsky Frank

Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

作者更正:溶瘤病毒疗法 DNX-2401 联合帕博利珠单抗治疗复发性胶质母细胞瘤:一项 1/2 期试验

Nassiri, Farshad; Patil, Vikas; Yefet, Leeor S; Singh, Olivia; Liu, Jeff; Dang, Rachel M A; Yamaguchi, Takafumi N; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley S; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim; Nair, Suresh G; Puduvalli, Vinay K; Aldape, Kenneth; Gao, Andrew; López-Janeiro, Álvaro; de Andrea, Carlos E; Alonso, Marta M; Boutros, Paul; Robbins, Joan; Mason, Warren P; Sonabend, Adam M; Stupp, Roger; Fueyo, Juan; Gomez-Manzano, Candelaria; Lang, Frederick F; Zadeh, Gelareh

Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

实体瘤内的多细胞免疫生态型可预测免疫检查点抑制剂在现实世界中的治疗效果

Wang, Xuefeng; Li, Tingyi; Eljilany, Islam; Soupir, Alex; Radmacher, Michael; Agius, Phaedra; Sukrithan, Vineeth; Ratan, Aakrosh; McCarter, Martin; Salhia, Bodour; Colman, Howard; Naqash, Abdul R; Puzanov, Igor; Arnold, Susanne; Marin-Acevedo, Julian A; Ganesan, Shridar; Churchman, Michelle; Hwu, Patrick; Rodriguez, Paulo C; Dalton, William S; Weiner, George J; Tarhini, Ahmad A

TIP-10. Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma

TIP-10. GBM AGILE研究最新进展:一项全球性的2/3期适应性平台试验,旨在评估多种治疗方案在初诊和复发性胶质母细胞瘤中的应用

Rodriguez, Annabelle; Yang, Chaojie; Gan, Wenqi; Karlinsey, Keaton; Zhou, Beiyan; Rich, Stephen S; Taylor, Kent D; Guo, Xiuqing; Rotter, Jerome I; Johnson, W Craig; Cornell, Elaine; Tracy, Russell P; Durda, J Peter; Gerszten, Robert E; Clish, Clary B; Blackwell, Thomas; Papanicolaou, George J; Lin, Honghuang; Raffield, Laura M; Vargas, Jose D; Vasan, Ramachandran; Manichaikul, Ani; Lim, Michael; Berry, Donald; Berry, Nicholas; Colman, Howard; de Groot, John; Ellingson, Benjamin; Gan, Hui; Hyddmark, E Viktoria; Johnson, Adam; Lassman, Andrew; Mellinghoff, Ingo; Perry, James; Sulman, Erik; Weller, Michael; Wen, Patrick; Cloughesy, Timothy; Network, GBM AGILE Trial